eCFR.io
Daily eCFR

Part 212—Current Good Manufacturing Practice for Positron Emission Tomography Drugs

Current Good Manufacturing Practice for Positron Emission Tomography Drugs

ContainsSubparts A–L
CorpusDaily eCFR
Displayed edition2026-04-15
Last updated2026-04-15

PART 212—CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS

Subparts

Authority21 U.S.C. 321, 351, 352, 355, 371, 374; Sec. 121, Pub. L. 105-115, 111 Stat. 2296.
Source74 FR 65431, Dec. 10, 2009, unless otherwise noted.